Emergent BioSolutions Inc.
EBS· NYSE
EBSEmergent BioSolutions Inc.
Filed Aug 5, 2011 · 10-Q · 36 days after period end · 0001367644-11-000044
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $88.14M | $62.14M |
| Net Income | $14.21M | $9.81M |
| EPS Diluted | $0.39 | $0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Emergent BioSolutions Inc. · CIK 1367644 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 5, 2011 · 36 d after period end
